Navigation Links
Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease
Date:3/19/2012

n people in the US are affected, while another estimated 12 million people are believed to have the disease but remain undiagnosed. COPD ranks as the third leading cause of death in the US and is a major cause of serious long-term disability. Arcapta Neohaler has not been shown to impact mortality or long-term disability caused by COPD.

According to 2011 GOLD Guidelines, bronchodilators are central to COPD management. Bronchodilators have different mechanisms of action and long-acting beta2-agonists (LABA) are among the classes of bronchodilators.

"The COPD Foundation is dedicated to providing information and support individuals with COPD," said John W. Walsh, president and co-founder of the US-based COPD Foundation. "The availability of this new, once-daily LABA is good news for COPD patients looking for new treatment options and for the millions of Americans that are living with this serious disease."

Once-daily Arcapta Neohaler also reduced the need for patients to use short-acting beta2-agonists (albuterol) as rescue therapy, measured as a secondary endpoint. Additionally, Arcapta Neohaler is the only COPD treatment approved with demonstrated improvements in health-related quality of life, as measured by the St George's Respiratory Questionnaire (SGRQ). The SGRQ is a disease-specific, patient-reported instrument that measures health-related quality of life for symptoms, activities and impact of daily life.

The safety and tolerability of Arcapta Neohaler was assessed in a clinical program of more than 5,400 COPD patients, with more than 2,500 who received Arcapta Neohaler for at least 12 weeks at doses of 75 mcg or higher. Adverse reactions were reported by 48% of patients treated with any dose of Arcapta Neohaler compared with 43% of patients treated with placebo. The most common serious adverse reactions were COPD exacerbation, pneumonia, angina pectoris, and atrial fibrillation, which occurred at similar rates across t
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data in NEJM shows Novartis drug Signifor® is first therapy to provide rapid, durable benefit for Cushings disease patients in Phase III study
2. FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery
3. Unity Management Group Subsidiary Announces First Contracts of 2012 with Purdue Pharma L.P. and Novartis
4. Endo Announces Potential Short-Term Supply Constraints of Certain Analgesic Medications as a Result of Temporary Shut Down of Novartis Facility
5. Novartis Consumer Health Inc. Issues Voluntary Nationwide Recall of Certain Over-the-Counter Products Due to Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps
6. Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec®
7. New Data Confirms Novartis Drug Afinitor® Significantly Extends Time Women With Advanced Breast Cancer Live Without Tumor Growth
8. Novartis Study Shows QTI571 Significantly Improved Walking Distance in Patients with Life-Threatening Pulmonary Arterial Hypertension
9. Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
10. Novartis Study Showed ACZ885 Provided Substantial Symptom Relief in 84% of Patients With the Most Serious Form of Childhood Arthritis
11. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 2015 Research and ... of the "Investigation Report on China,s Pranoprofen ... Originally discovered by Welfide (Mitsubishi Tanabe Pharma ... as an inflammatory drug, pranoprofen was later developed ... under the trade name of pranopulin for the ...
(Date:8/28/2015)... 28, 2015  Today, in final recognition of the ... Health Week, 1-800 Contacts is sharing how to keep ... lens wearers who do not properly care for their ... infections. Most contact lens wearers understand ... clean lens case is sometimes overlooked.  When proper steps ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... ) has announced the addition of the ... report to their offering. Developed by ... selective prostaglandin receptor agonist which effectively reduces intraocular ... by FDA, latanoprost (under the trade name of ...
Breaking Medicine Technology:Investigation Report on China's Pranoprofen Market, 2010-2019 21-800 Contacts Shares Tips on How to Clean Lens Cases 2China Latanoprost Market Investigation Report 2015-2019 2
(Date:8/31/2015)... (PRWEB) , ... August 31, ... ... Lifestyle Medicine (ACLM), the nation’s medical professional association for physicians and allied ... conjunction with the Lifestyle Medicine Foundation, announced today the establishment of the ...
(Date:8/31/2015)... ... ... MeYou Health ®, a social well-being company and wholly owned subsidiary of ... an in-app step tracker. , Walkadoo is a pedometer-based walking program that ... assign every Walkadoo member 10,000 steps a day (as is typical for many walking ...
(Date:8/31/2015)... ... 2015 , ... There’s big news for ZendyHealth , a Los Angeles-based ... Consumer driven health plans (CDHPs) are a growing phenomenon, and ZendyHealth has brought on ... company, and another to answer customers’ questions directly. , John Young, CEO of Consumerdriven, ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... introduces the Talent Management Division , a department devoted to helping organizations ... department. Talent management goes beyond selection, and The Brooks Group believes in offering ...
(Date:8/31/2015)... ... August 31, 2015 , ... Now here’s some good health news: Nearly ... least half your grains whole,” with the majority of Americans eating more whole grains ... Council (WGC) released these findings and others from the 2015 Whole Grains Consumer ...
Breaking Medicine News(10 mins):Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 2Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 3Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 2Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 3Health News:The Brooks Group Introduces Talent Management Division 2Health News:The Brooks Group Introduces Talent Management Division 3Health News:Most Americans Now Make Half Their Grains Whole 2Health News:Most Americans Now Make Half Their Grains Whole 3Health News:Most Americans Now Make Half Their Grains Whole 4Health News:Most Americans Now Make Half Their Grains Whole 5
... today said that a district court in the US has ... by Sanofi-Aventis and King Pharmaceuticals. // ,The company ... for the Eastern District of Virginia has issued an opinion ... No - 5061722 relating to Altace (Ramipril) drug and found ...
... Newborns who are breast fed experience less pain during ... by Canadian scientists.// ,Data from 1000 newborns ... effectiveness of breast milk and breast-feeding was compared to ... experienced by infants when blood samples were taken from ...
... According to a study conducted by LaSalle Bank in Chicago it ... and few grocery stores// are at an increased risk of dying ... is found to be a rise in the number of premature ... the residents were found to be obese and also suffer from ...
... Maharashtra are to meet in Bangalore next month to discuss ... has ravaged the four states and has infected lakhs of ... through Kolkata in 1954-55. ,Andhra Pradesh Health Minister ... in a representative at the meeting. Chikungunya was confined to ...
... liver disorders due to their consumption of a herbal remedy ... alert was issued by the Medicines and Healthcare products Regulatory ... soon appear on all products containing the plant extract. Black ... black snakeroot, rattlesnake root and squawroot, and has a market ...
... The Madhya Pradesh government Tuesday ascribed the increase in the ... 1,783 this year - to an increase in the number ... attention motion by Congress legislators Sajjan Singh Verma and Govind ... HIV/AIDS, Health Minister Ajay Vishnoi said: "The number of HIV ...
Cached Medicine News:Health News:Breast-fed Babies Experience Less Pain during Blood Tests 2
... The VariLite dual wavelength (532 nm ... ultimate skin lesion laser solution. This solid-state ... cutaneous lesions and acne vulgaris. VariLite offers ... vessels as well as deeper, larger vessels ...
... PREMIUM SURGICLIP II™ single use ... Super Interlock™ clips., ,The ... applier has application in many ... occlude vessels and other tubular ...
... Loading Units with Stainless Steel Staples for ... ,Utilizing a disposable loading unit, the LDS-2™ ... ligate the tissue within the cartridge jaw ... between the two closed clips. The instrument ...
... Utilizing a disposable loading unit, the LDS-2™ ... the tissue within the cartridge jaw and the ... closed clips. The instrument is activated by squeezing ... will go. The size of the clip is ...
Medicine Products: